Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
TKNO
Upturn stock ratingUpturn stock rating

Alpha Teknova Inc (TKNO)

Upturn stock ratingUpturn stock rating
$4.91
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: TKNO (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

5 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $11

1 Year Target Price $11

Analysts Price Target For last 52 week
$11Target price
Low$1.16
Current$4.91
high$10.37

Analysis of Past Performance

Type Stock
Historic Profit -21.17%
Avg. Invested days 25
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 273.08M USD
Price to earnings Ratio -
1Y Target Price 11
Price to earnings Ratio -
1Y Target Price 11
Volume (30-day avg) 5
Beta 0.41
52 Weeks Range 1.16 - 10.37
Updated Date 06/30/2025
52 Weeks Range 1.16 - 10.37
Updated Date 06/30/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.46

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -60.9%
Operating Margin (TTM) -50.68%

Management Effectiveness

Return on Assets (TTM) -12.26%
Return on Equity (TTM) -28.76%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 276154539
Price to Sales(TTM) 7.14
Enterprise Value 276154539
Price to Sales(TTM) 7.14
Enterprise Value to Revenue 7.22
Enterprise Value to EBITDA -6.23
Shares Outstanding 53440800
Shares Floating 10329574
Shares Outstanding 53440800
Shares Floating 10329574
Percent Insiders 10.95
Percent Institutions 82.17

Analyst Ratings

Rating 3
Target Price 11
Buy -
Strong Buy 3
Buy -
Strong Buy 3
Hold 2
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Alpha Teknova Inc

stock logo

Company Overview

overview logo History and Background

Alpha Teknova, Inc. was founded in 1975, initially as a reagent provider for the biotechnology industry. Over time, it expanded its offerings to include custom solutions and GMP-grade products. The company has focused on innovation and quality to serve the growing needs of biopharmaceutical and cell and gene therapy companies.

business area logo Core Business Areas

  • Cell Culture: Provides cell culture media, reagents, and supplements used in the development and manufacturing of biologics, cell therapies, and gene therapies.
  • Genomics and Proteomics: Offers reagents, buffers, and enzymes for genomic and proteomic research and development.
  • Molecular Biology: Supplies reagents for molecular biology applications, including PCR, cloning, and DNA/RNA purification.

leadership logo Leadership and Structure

The leadership team consists of key executives responsible for driving the company's strategy and operations. The organizational structure is designed to support innovation, quality control, and customer service.

Top Products and Market Share

overview logo Key Offerings

  • Cell Culture Media: Cell culture media for various cell types used in biologics and cell therapy production. While precise market share data is difficult to pinpoint, the competition is fierce with companies like Thermo Fisher Scientific and Cytiva (Danaher).
  • GMP Buffers and Reagents: GMP-grade buffers and reagents for biopharmaceutical manufacturing, critical for ensuring product quality and regulatory compliance. No market share or revenue data is available. Competitors include Avantor and Merck.
  • Custom Solutions: Custom reagent formulation and manufacturing services tailored to specific customer needs. Market share and revenue data are unavailable. Competitors include Lonza and WuXi AppTec.

Market Dynamics

industry overview logo Industry Overview

The life sciences reagent market is experiencing substantial growth, driven by advancements in biotechnology, biopharmaceutical development, and cell and gene therapies. The market is competitive, with many players offering similar products and services.

Positioning

Alpha Teknova positions itself as a provider of high-quality reagents and custom solutions for the life sciences industry, with a focus on GMP-grade products and customer service. It competes with larger players in the market.

Total Addressable Market (TAM)

The total addressable market for life science reagents is estimated to be in the tens of billions of dollars. Alpha Teknova's position reflects its effort to become a go-to vendor for biopharmaceutical companies

Upturn SWOT Analysis

Strengths

  • High-quality products
  • Custom solution capabilities
  • Focus on GMP-grade manufacturing
  • Strong customer relationships

Weaknesses

  • Smaller scale compared to major competitors
  • Limited brand recognition
  • Reliance on specific market segments

Opportunities

  • Expanding into new geographic markets
  • Developing innovative products and services
  • Acquiring complementary businesses
  • Capitalizing on the growth in cell and gene therapies

Threats

  • Intense competition
  • Pricing pressures
  • Regulatory changes
  • Supply chain disruptions

Competitors and Market Share

competitor logo Key Competitors

  • Thermo Fisher Scientific (TMO)
  • Danaher Corporation (DHR)
  • Avantor, Inc. (AVTR)

Competitive Landscape

Alpha Teknova faces strong competition from larger, more established players in the life sciences reagent market. To compete effectively, it needs to focus on innovation, customer service, and niche market segments.

Growth Trajectory and Initiatives

Historical Growth: Historical growth trends can only be analyzed by looking into past earnings data.

Future Projections: Future growth projections are based on analyst estimates and market conditions.

Recent Initiatives: Recent strategic initiatives would need to be researched from press releases.

Summary

Alpha Teknova is a life science reagent company that is expanding its custom solutions and GMP-grade products and services. Its strengths include custom solution capabilities and GMP-grade manufacturing. Its weaknesses include the fact that it is a smaller company compared to its competitors. The opportunities are to capitalize on growth in cell and gene therapies. The threat is intense competition.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Industry Reports
  • Analyst Reports

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Alpha Teknova Inc

Exchange NASDAQ
Headquaters Hollister, CA, United States
IPO Launch date 2021-06-25
President, CEO & Director Mr. Stephen Gunstream
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 173
Full time employees 173

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.